Xometry stock hits all-time high at 114.27 USD

Xometry reached an all-time high of $114.27, up 96.6% over the past year, with a reported market capitalization of $6.43 billion and trailing-12-month revenue growth of 34%. In Q3 2026, revenue rose 40% year over year to $252.4 million and adjusted EPS of $0.28 beat forecasts; the company also recorded its first quarter of GAAP net income. The article says the stock declined despite the results and that InvestingPro analysis views it as overvalued relative to its Fair Value estimate.

Analysis

The key signal is not the earnings beat; it is the market’s response to it. A pullback despite better-than-expected results suggests investors may be underwriting a high bar for continued growth and durable profitability. The first GAAP-profitable quarter is not yet proof of a stable earnings base: marketplace mix, fulfillment costs, and customer-acquisition spending can make quarterly profit conversion uneven. Verify the source and composition of GAAP income before treating this as an earnings-power inflection.

Over the next 1–3 months, the critical tests are forward revenue growth, gross-profit dollars and margin, and management’s outlook—not headline EPS alone. If growth holds while profitability persists, the platform’s ability to match customers with distributed manufacturing capacity could support operating leverage and pressure traditional sourcing channels. Conversely, weaker order activity or price competition could leave Xometry absorbing costs to sustain growth, while suppliers face pressure to accept less attractive work. Protolabs is a relevant competitive reference, but relative valuation and operating data are needed before expressing a pair trade.

The stock’s prior run-up raises the risk that good results are already reflected in expectations, but a third-party fair-value estimate is not evidence of mispricing. The contrarian opportunity is to wait for the pullback to distinguish multiple compression from deteriorating fundamentals. Over 6–18 months, repeat demand and sustained GAAP profitability would validate the marketplace model; a single profitable quarter does not. A sustained failure to hold or reclaim the reported $114.27 high alongside weakening forward indicators would weaken the bullish setup.

Key Decisions for Investors

• Do not chase the milestone or treat the earnings beat as a standalone buy signal. Reassess after the next outlook update and inspect gross-profit dollars, margin, order activity, and the drivers of GAAP net income.
• Keep XMTR on a conditional long watchlist: consider exposure only if the stock stabilizes after the post-results pullback and operating indicators confirm growth with durable profit conversion. The thesis is falsified by material forward-growth deceleration or renewed losses without a clear, temporary cause.
• Avoid an outright short based solely on a third-party fair-value claim. If XMTR fails to reclaim or hold $114.27 and forward indicators deteriorate, evaluate a defined-risk bearish structure; first verify option liquidity and the next catalyst date.